From comparable starts in 2000, Africa and Europe diverged massively.
Trigger
2005 ICMJE
Gap Now
8x
Africa Growth
Linear
Europe Growth
Exponential
Key Finding
Africa's 17x absolute growth outpaced the United States 2.9x growth, but the absolute gap widened from 15,731 to 36,635 trials.
Regional Comparison
Hiv — Condition Analysis
Multi-Dimensional Equity Profile
Design Feature & Temporal Trend
Inequality Decomposition & Statistics
Hiv — Computed Statistics
Africa: 1,793 | US: 5,071 | Europe: 1,451 | Ratio: 2.8x
Africa share: 21.6% | HHI4-region = 0.449 | Shannon H = 1.47 bits
Adaptive: AF 140 vs US 2,986 (21.3x gap)
Ginicountry = 0.857 [0.61, 0.90] | αpower-law = 1.40 | Atkinson A(2) = 0.979
KL(obs||uniform) = 2.93 bits | ρSpearman(pop, trials/M) = −0.01
Why It Matters
In 2000, Africa and Europe started from comparable positions in trial registration. The 2005 ICMJE mandate requiring trial registration for publication triggered an exponential surge in European registrations that Africa never matched. The result: a structural divergence now embedded in global scientific infrastructure, with Africa stuck in linear growth while Europe entered a discovery orbit.
The Evidence 133 words · target 156
In the history of clinical research, has the volume gap between Africa and high-income regions widened or narrowed over twenty-five years of trial registration? This longitudinal analysis tracked trial volumes across five epochs from 2000 to 2025 using ClinicalTrials.gov first-posted-date metadata for Africa and comparator regions. Africa grew from 678 trials in 2000-2005 to 11,599 in 2021-2025, while the United States grew from 16,409 to 48,234. Africa's 17x absolute growth outpaced the United States 2.9x growth, but the absolute gap widened from 15,731 to 36,635 trials. The 2005 ICMJE mandate requiring trial registration for journal publication triggered exponential European growth that Africa never matched proportionally. These findings reveal a grand divergence where proportional equity is receding despite absolute growth. Interpretation is limited by retrospective registration of older trials which may distort early-epoch counts.
Sentence Structure
Question
In the history of clinical research, has the volume gap between Africa and high-income regions widened or narrowed over twenty-five years of trial registration?
Dataset
This longitudinal analysis tracked trial volumes across five epochs from 2000 to 2025 using ClinicalTrials.gov first-posted-date metadata for Africa and comparator regions.
Method
Africa grew from 678 trials in 2000-2005 to 11,599 in 2021-2025, while the United States grew from 16,409 to 48,234.
Primary Result
Africa's 17x absolute growth outpaced the United States 2.9x growth, but the absolute gap widened from 15,731 to 36,635 trials.
Robustness
The 2005 ICMJE mandate requiring trial registration for journal publication triggered exponential European growth that Africa never matched proportionally.
Interpretation
These findings reveal a grand divergence where proportional equity is receding despite absolute growth.
Boundary
Interpretation is limited by retrospective registration of older trials which may distort early-epoch counts.